Dermatoosteolysis Kirghizian Type C1857301
A rare inherited disorder affecting skin and bone development, causing skin lesions and skeletal abnormalities. Care focuses on managing skin problems and supporting bone health.
Key facts at a glance
- ICD-10
- Q79.9
- ICD-11
- LA00.0
- Body system
- musculoskeletal
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Pathological fractures
Joint pain or stiffness
(musculoskeletal)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Chronic bone pain
(musculoskeletal)Joint swelling
(musculoskeletal)Limited joint mobility
(musculoskeletal)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Medication management with follow-up
Active treatment with regular monitoring by a healthcare provider is recommended.
Regular dermatological and orthopedic assessment
Comprehensive monitoring of skin lesions and bone involvement through scheduled clinical evaluations and imaging studies to track disease progression and guide intervention timing.
Orthopedic intervention for skeletal deformities
Surgical correction of bone abnormalities including joint deformities and limb length discrepancies using appropriate fixation techniques and rehabilitation protocols.
Additional treatment options
Joint mobility and strength preservation program
Targeted physical therapy to maintain range of motion, prevent contractures, and preserve functional mobility through guided exercises and manual techniques.
physical_therapyPain and inflammation management
Pharmacological approaches using general pain management strategies and anti-inflammatory agents as needed to improve quality of life and facilitate therapy participation.
medicationSkin protection and wound care measures
Implementation of protective skin care routines including gentle cleansing, moisturizing, and avoidance of trauma to prevent secondary infections and complications.
lifestyleWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Dermatoosteolysis Kirghizian Type C1857301?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Dermatoosteolysis Kirghizian Type C1857301. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy